A Study of Long-term Outcomes of Anxiety Treatment in Children

Overview

About this study

The purpose of this study seeks to assess and compare long-term treatment outcomes for children who received specialty clinic intervention to those who did not, including whether psychopharamacological treatment was utilized.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Subjects were identified in a previous study as having been newly diagnosed in 2010 with an anxiety disorder. The previously identified subjects will be included to obtain follow-up data.

Exclusion Criteria:

Subjects who decline research authorization.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Stephen Whiteside, Ph.D., L.P.	Closed for enrollment	Contact information: Melissa Hord Ph.D.

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Stephen Whiteside, Ph.D., L.P.

Closed for enrollment

Contact information:

Melissa Hord Ph.D.

More information

Publications

Publications are currently not available

Clinical Trials